Home|Journals|Articles by Year|Audio Abstracts

Review Article

IJMDC. 2023; 7(4): 722-726

Allergic rhinitis and its management: a review article

Abdullah Awon A. Alsalooli, Yazeed Fahad M. Alshahrani, Nawaf Saeed O. Al Shahrani, Nawaf Mohammad J. Altayyib, Fahad Mohammed Abdullah Al Yahya, Abdullah Mesfer M. Al Qamshah, Fahad Saud M. Alrmthi, Ahmed Y. Al-Ameer.


Allergic rhinitis (AR) is a common disease worldwide affecting nearly 10%-20% of the population, a severe form of AR could have a significant impact on the quality of life, sleep, and work performance which places a marked financial and logistical burden on healthcare systems. Regardless of these harmful outcomes, the disease has been generally overlooked, with physicians and researchers only recently starting to pay more attention to it. A complete medical history and physical examination are the cornerstone for diagnosing AR. Allergy testing is considered to be an important part to confirm the underlying cause of AR. Referral to an allergist should be considered when the diagnosis of AR is in doubt. The current treatment modalities for AR include the following: patient education, strategies to prevent irritants and allergens, medication, allergen immunotherapy, nasal irrigates, and other uncommon treatments like surgery and acupuncture. Currently, pharmacotherapy comprises short-term nasal decongestants, antihistamines, leukotriene receptor antagonists, nasal/oral corticosteroids, and mast cell stabilizers. Patients with the disease usually do not realize the impact of the disease on their quality of life and daily living activities. Therefore, health workers must pay more attention to the early development of the illness to be diagnosed correctly and treated efficiently. This study reviews AR and its management.

Key words: Allergic rhinitis, prevalence, treatment.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.